KFSH&RC Sets New Standard In Infectious Disease Diagnosis With Genetic Protocol

King Faisal Specialist Hospital and Research Centre (KFSH&RC) has pioneered a metagenomic protocol to diagnose infectious diseases that evade traditional methods. This protocol involves an extensive genetic analysis of microbial DNA in patients unresponsive to conventional treatments. By leveraging advanced sequencing technologies, KFSH&RC aims to eliminate undiagnosed cases, improving treatment plans, outcomes, and reducing hospital stays.

The protocol employs second and third-generation sequencing technologies. These allow for the simultaneous sequencing of millions of DNA or RNA fragments. This capability enables the detection of multiple pathogens in one process, including those difficult to culture or identify using traditional techniques. Such comprehensive analysis is crucial for tracking disease outbreaks, controlling infections, and discovering mutations.

Statistics reveal that half of blood samples and diarrheal diseases remain unidentified at the pathogen level. This issue extends to nearly two-thirds of encephalitis cases, up to a quarter of pneumonia cases, and 20% of sepsis cases. These figures underscore the need for an advanced diagnostic protocol using whole-genome sequencing technology.

This innovative approach has been applied to over 100 patients with unidentified microbial infections. Analysis showed that half of these cases were antibiotic-resistant. Such insights are invaluable for doctors in selecting more effective treatments against these infections. The rapid and precise diagnosis provided by this protocol allows doctors to identify the primary virus, fungus, or bacterium causing the infection within 24 hours.

This swift diagnosis timeframe is exceptional and available in very few hospitals worldwide. It enables precise treatment tailored to the patient’s genetic makeup and the pathogen’s characteristics. The ability to deliver highly accurate results quickly significantly impacts treatment efficacy and patient recovery times.

KFSH&RC's Global Recognition

KFSH&RC has achieved notable rankings for its excellence in healthcare. It ranked first in the Middle East and Africa and 20th globally among the world’s top 250 Academic Medical Centers for two consecutive years. Additionally, it was recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East according to the 2024 Brand Finance rankings.

Furthermore, Newsweek magazine listed KFSH&RC among the world's best 250 hospitals. These accolades highlight its commitment to providing cutting-edge medical care and advancing healthcare standards both regionally and globally.

The metagenomic protocol developed by KFSH&RC represents a significant advancement in diagnosing infectious diseases. Its application not only enhances patient outcomes but also positions KFSH&RC as a leader in medical innovation.

With inputs from SPA